You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GYRE Sale Disclosure
Ye Weiguo · SEC Form 4 · Filed Jun 22, 2026
Sale
Calculated transaction value
$18.45K
Ye Weiguo Chief Operating Officer
GYRE
Gyre Therapeutics
GYRE
Transaction date
Jun 9, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 13 days later
GYRE daily price context
Close on/before transaction
$6.13
Jun 9, 2026
First close after public filing
$6.13
Jun 23, 2026
30-day return after filing
-3.1%
Through Jul 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,000 shares @ $6.15
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-025950
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$76.95K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 18, 2026 | $2.25K |
| Gyre Therapeutics, Inc. GYRE | Sale | Jun 18, 2026 | $19.05K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 18, 2026 | $0 |
| Gyre Therapeutics, Inc. GYRE | Sale | Jun 10, 2026 | $31.2K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 10, 2026 | $0 |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 10, 2026 | $3.75K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 9, 2026 | $2.25K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 9, 2026 | $0 |
| Gyre Therapeutics, Inc. GYRE Current | Sale | Jun 9, 2026 | $18.45K |